Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

NCT01677871 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chronic Liver Disease With Tuberclosis

Interventions

DRUG: 2HRZE/4HR
DRUG: 2HRLE/4HR
DRUG: 9HLE
DRUG: 9RLE

Sponsor

Institute of Liver and Biliary Sciences, India